Click or scroll

The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.

Close

While running a triathlon, Andrea stumbled and realized something was wrong.

Pause Background Motion

Her condition worsened. Within months, she was forced to walk with a cane.


Then, finally, came the diagnosis.

She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.

She had ALS, a condition affecting more than 200,000 people around the world.

Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.

Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.

Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.

Lives can change when you design neuroscience trials with speed and precision.

  • Utilize the right experts, with the right specialization
  • Find the patients you need and earn their trust
  • Satisfy global regulations to get your treatment to patients safely and quickly
  • Design studies and endpoints with market access in mind

What we do, we do

With Heart

Our Experts

Our neuroscience specialists collaborate to get your treatment to patients faster.

Andreas Lysandropoulos, MD, PH.D

Our Experts

Andreas Lysandropoulos, M.D., Ph.D.

Senior Vice President, Global Neuroscience Therapeutic Area Head

With 15+ years of experience as a clinical neurologist, principal investigator, and medical leader, Andreas works with you to create an effective development strategy. Once the plan is in place, he and his team lead all aspects of execution — ensuring your assets are approved quickly and efficiently.


"For me, ‘With Heart’ means with passion and empathy. It is my mission to gather people around a common cause and inspire everybody to reflect on and be passionate about what we do together because it matters to patients who rely on us all for a better life."

Our diverse neuroscience experiences ensure you get the expertise you need across all indications of neurology and psychiatry.

500+ Projects in the past 5 years

Innovative trial designs allow us to optimize your trials for maximum impact.

Innovative Trial Designs

Neuroscience sites around the world allow us to accelerate study startups.

  • North America
  • South America
  • Europe
  • APAC
  • Middle East & Africa
3,500+ neuroscience sites worldwide

Advanced modeling and simulation allow us to predict drug effects ahead of time, saving time, money, and resources.

Advanced modeling and simulation

And our patient-first approach results in deeper, more relevant insights for trial design and execution.

TACTICS

Tactics

BENEFITS MAY INCLUDE

Benefits

What can we do to help you change patient lives?

See neuroscience capabilities Visit all therapeutic areas Explore neuroscience careers

Want our latest insights for neuroscience?

Learn more

Ready to speak to someone on our team?

Get in touch

Are you a patient interested in a clinical trial?

Learn more

The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.

Close

We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.

Who we are,

Parexel is proudly among the world’s largest
clinical research organizations

A dedicated CRO providing the full range of Phase I to IV clinical development services and leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders and sites to design and deliver clinical trials with patients in mind, to make clinical research a care option for anyone, anywhere.